MedTrace Logo

CD4 Cell Count at Antiretroviral Therapy Initiation or Re- Initiation

NCT07760324 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 151

Last updated 2026-08-12

No results posted yet for this study

Summary

The primary purpose of this study is to assess the burden of advanced HIV disease (CD4 cell count \<200 or \<350 cells/μL) among new patients and those returning to care after a gap in treatment, and the extent to which low coverage of CD4 cell count measurement among these patients may prevent adequate management of those with advanced HIV disease.

Conditions

  • HIV - Human Immunodeficiency Virus

Sponsors & Collaborators

  • Centre for Infectious Disease Research in Zambia

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-28
Primary Completion
2027-12-31
Completion
2028-03-31

Countries

  • Zambia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07760324 on ClinicalTrials.gov